StonvexLoading…
StonvexStonvexStonvexCore line items from FISV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 |
|---|---|---|---|---|---|
Revenue | $5.15B | $5.03B | $5.13B | $13.11B | $8.59B |
Operating Income | Not available | $918.00M | $1.40B | $2.56B | $1.71B |
Net Income | Not available | $571.00M | $851.00M | $1.75B | $1.27B |
EPS (Diluted) | $1.96 | $1.07 | $1.51 | $2.68 | $1.94 |
Total Assets | Not available | $80.55B | $80.40B | $75.64B | $77.21B |
Total Liabilities | Not available | $54.33B | $53.88B | $44.50B | $45.24B |
Cash & Equivalents | Not available | $829.00M | $1.18B | $3.38B | $3.06B |
Free Cash Flow OCF − CapEx | Not available | $141.00M | $313.00M | $1.84B | $1.09B |
Shares Outstanding | Not available | 535.40M | 564.70M | 651.00M | 654.00M |